沃沙隆沙星(AG-7352，SPC-595，SNS 595，Velexin)是一种引起位点选择性DNA损伤的拓扑异构酶II抑制剂。现正接受第三期临床试验，研究由SunEX赞助的急性髓细胞性白血病（AML）和卵巢癌。
tert-Butyl 6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate
Ethyl 3-(2,6-dichloropyridin-3-yl)-3-oxopropanoate
(3S,4S)-tert-Butyl 3-((tert-butoxycarbonyl)(methyl)amino)-4-hydroxypyrrolidine-1-carboxylate
Ethyl 7-chloro-4-oxo-1-(thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylate
tert-Butyl 3-hydroxy-4-(methylamino)pyrrolidine-1-carboxylate
(4-Methoxy-pyrrolidin-3-yl)methyl-carbamic acid tert-butyl ester
(3S,4S)-1-Benzyl-3,4-dihydroxypyrrolidine-2,5-dione
tert-Butyl 3-bromo-4-hydroxypyrrolidine-1-carboxylate
(3S,4S)-tert-Butyl 3-hydroxy-4-(methylamino)pyrrolidine-1-carboxylate (S)-2-hydroxysuccinate
